NASDAQ:GOSS

Gossamer Bio Stock News

Healthcare > Biotechnology

Buy GOSS

*Your capital is at risk

$0.188

-0.0119 (-5.94%)

At Close: Jun 03, 2026

11 Top Penny Stocks To Buy Now According To Insiders

01:32pm, Friday, 17'th Nov 2023

Ever wonder what signals to look for in the stock market today? Let's talk about insider buying – a goldmine of clues that could lead you to the next prospect to add to your list of penny stocks to

5 Penny Stocks To Buy Now According To Insiders

12:52pm, Wednesday, 15'th Nov 2023

Penny stocks are often priced under $5 per share. They attract traders seeking big gains.

Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update

07:31am, Thursday, 09'th Nov 2023

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary

Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs

04:08pm, Tuesday, 03'rd Oct 2023

SAN DIEGO--(BUSINESS WIRE)---- $GOSS--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of

Gossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023

07:44am, Thursday, 07'th Sep 2023

Gossamer Bio stock struggles from lack of near-term catalysts: analysts

03:04pm, Thursday, 27'th Jul 2023

Shares of Gossamer Bio fell Thursday, and the company earned a downgrade from analysts at UBS. Citing a "lack of near-term catalysts," the firm downgraded the biopharmaceutical company to Neutral fr

Gossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE Results

04:16pm, Monday, 24'th Jul 2023

Gossamer Bio: Merck's STELLAR Data Impressive, But Game Not Over For Seralutinib

04:12am, Sunday, 02'nd Apr 2023

Merck's Sotatercept showed significant improvements in PAH patients in Phase 3 STELLAR trial with a primary endpoint of improvements in pulmonary vascular resistance, 6-minute walk distance, and NT-pr

10 Top Penny Stocks To Watch With High Short Interest This Week

07:30pm, Tuesday, 31'st Jan 2023 PennyStocks

More short squeeze penny stocks to watch before February 2023. The post 10 Top Penny Stocks To Watch With High Short Interest This Week appeared first on Penny Stocks to Buy, Picks, News and Informati

10 Top Penny Stocks To Watch With High Short Interest This Week

02:30pm, Tuesday, 31'st Jan 2023

Gossamer: Disappointing Phase 2 Results But Too Cheap To Ignore

04:48am, Monday, 30'th Jan 2023

Gossamer's TORREY showed stat sig PVR improvement, but the 6MWD was under what investors were hoping for; this led to a +70% decline in share price. Seralutnib is entering phase 3 with an adapted desi

4 Penny Stocks To Watch With High Short Interest In January 2023

05:14pm, Friday, 27'th Jan 2023 PennyStocks

Are these penny stocks ready to squeeze? The post 4 Penny Stocks To Watch With High Short Interest In January 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks To Watch With High Short Interest In January 2023

12:14pm, Friday, 27'th Jan 2023

Gossamer Bio (GOSS) Upgraded to Buy: What Does It Mean for the Stock?

05:00pm, Wednesday, 04'th Jan 2023 Zacks Investment Research

Gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Gossamer Bio (GOSS) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

02:35pm, Wednesday, 04'th Jan 2023 Zacks Investment Research

Gossamer Bio (GOSS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estima

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by